| Year |
Citation |
Score |
| 2024 |
Mukund K, Alva-Ornelas JA, Maddox AL, Murali D, Veraksa D, Saftics A, Tomsic J, Frankhouser D, Razo M, Jovanovic-Talisman T, Seewaldt VL, Subramaniam S. Molecular Atlas of HER2+ Breast Cancer Cells Treated with Endogenous Ligands: Temporal Insights into Mechanisms of Trastuzumab Resistance. Cancers. 16. PMID 38339304 DOI: 10.3390/cancers16030553 |
0.314 |
|
| 2023 |
Jinna ND, Van Alsten S, Rida P, Seewaldt VL, Troester MA. Molecular features of androgen-receptor low, estrogen receptor-negative breast cancers in the Carolina breast cancer study. Breast Cancer Research and Treatment. 201: 171-181. PMID 37438515 DOI: 10.1007/s10549-023-07014-x |
0.442 |
|
| 2023 |
Vidal CM, Ouyang C, Qi Y, Mendez-Dorantes C, Coblentz A, Alva-Ornelas JA, Stark JM, Seewaldt VL, Ann DK. Arginine regulates HSPA5/BiP translation through ribosome pausing in triple-negative breast cancer cells. British Journal of Cancer. PMID 37386138 DOI: 10.1038/s41416-023-02322-x |
0.553 |
|
| 2023 |
Jinna N, Alsten SV, Rida P, Seewaldt V, Troester M. Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study. Research Square. PMID 36993425 DOI: 10.21203/rs.3.rs-2693555/v1 |
0.442 |
|
| 2023 |
Morrell BL, Morrell MB, Ball JA, Ochoa AC, Seewaldt VL. Disparities in the use of screening breast magnetic resonance imaging persist in Louisiana after the Affordable Care Act: A question of access, policy, institutional support, or something else? Cancer. PMID 36632769 DOI: 10.1002/cncr.34605 |
0.439 |
|
| 2022 |
Jinna N, Jovanovic-Talisman T, LaBarge M, Natarajan R, Kittles R, Sistrunk C, Rida P, Seewaldt VL. Racial Disparity in Quadruple Negative Breast Cancer: Aggressive Biology and Potential Therapeutic Targeting and Prevention. Cancers. 14. PMID 36139643 DOI: 10.3390/cancers14184484 |
0.556 |
|
| 2022 |
Maddox AL, Brehove MS, Eliato KR, Saftics A, Romano E, Press MF, Mortimer J, Jones V, Schmolze D, Seewaldt VL, Jovanovic-Talisman T. Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer. Cancers. 14. PMID 35681773 DOI: 10.3390/cancers14112795 |
0.472 |
|
| 2022 |
Jones VC, Kruper L, Mortimer J, Ashing KT, Seewaldt VL. Understanding drivers of the Black:White breast cancer mortality gap: A call for more robust definitions. Cancer. PMID 35578909 DOI: 10.1002/cncr.34243 |
0.446 |
|
| 2021 |
Frankhouser DE, Dietze E, Mahabal A, Seewaldt VL. Vascularity and Dynamic Contrast-Enhanced Breast Magnetic Resonance Imaging. Frontiers in Radiology. 1: 735567. PMID 37492179 DOI: 10.3389/fradi.2021.735567 |
0.381 |
|
| 2021 |
Shalabi SF, Miyano M, Sayaman RW, Lopez JC, Jokela TA, Todhunter ME, Hinz S, Garbe JC, Stampfer MR, Kessenbrock K, Seewaldt VE, LaBarge MA. Evidence for accelerated aging in mammary epithelia of women carrying germline or mutations. Nature Aging. 1: 838-849. PMID 35187501 DOI: 10.1038/s43587-021-00104-9 |
0.544 |
|
| 2021 |
Wright N, Gong Z, Kittles R, Natarajan R, Jovanovic-Talisman T, Rida P, LaBarge M, Seewaldt V. Kinesin Family Member C1 (KIFC1/HSET): A Potential Actionable Biomarker of Early Stage Breast Tumorigenesis and Progression of High-Risk Lesions. Journal of Personalized Medicine. 11. PMID 34945833 DOI: 10.3390/jpm11121361 |
0.417 |
|
| 2021 |
Skaar DA, Dietze EC, Alva-Ornelas JA, Ann D, Schones DE, Hyslop T, Sistrunk C, Zalles C, Ambrose A, Kennedy K, Idassi O, Miranda Carboni G, Gould MN, Jirtle RL, Seewaldt VL. Epigenetic Dysregulation of Imprinting and Triple-Negative Breast Cancer. Cancers. 13. PMID 34885139 DOI: 10.3390/cancers13236031 |
0.584 |
|
| 2021 |
Seewaldt VL, Bernstein L. Reply to Corrections: Breast cancer screening guidelines for young women of color. Cancer. PMID 34730854 DOI: 10.1002/cncr.33989 |
0.499 |
|
| 2021 |
Seewaldt VL, Bernstein L. The perils of generalization: Rethinking breast cancer screening guidelines for young women of color. Cancer. PMID 34427914 DOI: 10.1002/cncr.33840 |
0.499 |
|
| 2021 |
Zirbes A, Joseph J, Lopez JC, Sayaman RW, Basam M, Seewaldt VL, LaBarge MA. Changes in Immune Cell Types with Age in Breast are Consistent with a Decline in Immune Surveillance and Increased Immunosuppression. Journal of Mammary Gland Biology and Neoplasia. PMID 34341887 DOI: 10.1007/s10911-021-09495-2 |
0.317 |
|
| 2021 |
Miyano M, Sayaman RW, Shalabi SF, Senapati P, Lopez JC, Angarola BL, Hinz S, Zirbes A, Anczukow O, Yee LD, Sedrak MS, Stampfer MR, Seewaldt VL, LaBarge MA. Breast specific molecular clocks comprised of ELF5 expression and promoter methylation identify individuals susceptible to cancer initiation. Cancer Prevention Research (Philadelphia, Pa.). PMID 34140348 DOI: 10.1158/1940-6207.CAPR-20-0635 |
0.469 |
|
| 2021 |
Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, Duan Y, Seewaldt VL, Yu D. Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer. American Journal of Cancer Research. 11: 2005-2024. PMID 34094666 |
0.516 |
|
| 2021 |
Maddox AL, Brehove MS, Tobin SJ, Wakefield DL, Eliato KR, Alva-Ornelas J, Jones V, Schmolze D, Mortimer J, Seewaldt VL, Jovanovic-Talisman T. Molecular Assessment of HER2 in Breast Cancer Biophysical Journal. 120: 359a. DOI: 10.1016/J.BPJ.2020.11.2218 |
0.541 |
|
| 2020 |
Dietze E, Jones V, Seewaldt V. Breast Self-Examination - the case for a second look. Current Breast Cancer Reports. 12: 118-124. PMID 34149989 DOI: 10.1007/s12609-020-00358-z |
0.433 |
|
| 2020 |
Lelièvre SA, Bellanger M, Seewaldt V, Talhouk RS, Terry MB. Editorial: Perspectives in Primary Prevention Research for Breast Cancer: A Focus on Gene-Environment Interactions. Frontiers in Medicine. 7: 621959. PMID 33363192 DOI: 10.3389/fmed.2020.621959 |
0.46 |
|
| 2020 |
Jones VC, Dietze EC, Jovanovic-Talisman T, McCune JS, Seewaldt VL. Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer. Frontiers in Public Health. 8: 509714. PMID 33194937 DOI: 10.3389/fpubh.2020.509714 |
0.563 |
|
| 2020 |
Seewaldt VL. Time for action: The Patient Protection and Affordable Care Act Medicaid expansion significantly improves breast cancer care for women in Louisiana. Cancer. PMID 33141930 DOI: 10.1002/cncr.33264 |
0.386 |
|
| 2020 |
Frankhauser DE, Jovanovic-Talisman T, Lai L, Yee LD, Wang LV, Mahabal A, Geradts J, Rockne RC, Tomsic J, Jones V, Sistrunk C, Miranda-Carboni G, Dietze EC, Erhunmwunsee L, Hyslop T, ... Seewaldt VL, et al. Spatiotemporal strategies to identify aggressive biology in precancerous breast biopsies. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. e1506. PMID 33001587 DOI: 10.1002/wsbm.1506 |
0.566 |
|
| 2020 |
Khawaled S, Nigita G, Distefano R, Oster S, Suh SS, Smith Y, Khalaileh A, Peng Y, Croce CM, Geiger T, Seewaldt VL, Aqeilan RI. Pleiotropic tumor suppressor functions of WWOX antagonize metastasis. Signal Transduction and Targeted Therapy. 5: 43. PMID 32300104 DOI: 10.1038/S41392-020-0136-8 |
0.304 |
|
| 2020 |
Yee LD, Mortimer JE, Natarajan R, Dietze EC, Seewaldt VL. Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin. Frontiers in Endocrinology. 11: 58. PMID 32153503 DOI: 10.3389/Fendo.2020.00058 |
0.464 |
|
| 2020 |
Ramos CA, Ouyang C, Qi Y, Chung Y, Cheng CT, LaBarge MA, Seewaldt VL, Ann DK. A Non-canonical Function of BMAL1 Metabolically Limits Obesity-Promoted Triple-Negative Breast Cancer. Iscience. 23: 100839. PMID 32058954 DOI: 10.1016/J.Isci.2020.100839 |
0.428 |
|
| 2020 |
Natarajan R, Aljaber D, Au D, Thai C, Sanchez A, Nunez A, Resto C, Chavez T, Jankowska MM, Benmarhnia T, Yang JA, Jones V, Tomsic J, McCune JS, Sistrunk C, ... ... Seewaldt VL, et al. Environmental Exposures during Puberty: Window of Breast Cancer Risk and Epigenetic Damage. International Journal of Environmental Research and Public Health. 17. PMID 31941024 DOI: 10.3390/Ijerph17020493 |
0.3 |
|
| 2020 |
Shalabi S, Tomsic J, Hamad N, Neuhausen S, Atallah O, Mustafa S, AbuHeibeh A, Abdul-Shafi O, Maslamani N, Karmi B, Abu-Kishik O, Shawar J, Aqeilan H, Awad A, Aqeilan R, ... ... Seewaldt V, et al. Abstract C057: Whole-exome sequencing of DNA from Palestinian women undergoing surgical evaluation for breast cancer Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C057 |
0.532 |
|
| 2020 |
Serrano M, Sanchez A, Thai C, Nerio K, Resto C, Garcia M, Chavez TA, Kruper LL, Jones VC, Yee LD, Nuñez A, Rippberger EJ, Wong AK, Chávez NR, Herold K, ... ... Seewaldt VL, et al. Abstract B119: Receptiveness of metformin as a breast cancer prevention drug within the Hispanic community Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B119 |
0.425 |
|
| 2020 |
Polonsky M, Round K, Seewaldt V, Cai L. Abstract B117: Analysis of luminal breast cancer tumor microenvironment using seqFISH Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B117 |
0.573 |
|
| 2020 |
Herold K, Yee LD, Kalu CM, Kruper LL, Jones VC, Polverini AC, Clancy S, Chavez TA, Alva-Ornelas JA, Chavez NR, Rippberger EJ, Tomsic J, Sistrunk C, Idassi O, Schmolze DB, ... ... Seewaldt VL, et al. Abstract B109: Architecture of increased breast cancer risk Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B109 |
0.494 |
|
| 2020 |
Rippberger E, Chavez N, Chavez T, Thai C, Sanchez A, Wong A, Herold K, Nenez A, Rounds K, Seewaldt V. Abstract A086: Factors influencing women's attitudes toward participation in breast cancer clinical research Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-A086 |
0.52 |
|
| 2020 |
Chavez TA, Thai C, Sanchez A, Kruper LL, Jones VC, Clancy S, Polverini AC, Yee LD, Vito CA, Chávez NR, Nuñez A, Rippberger EJ, Wong AK, Herold K, Kalu CMK, ... ... Seewaldt VL, et al. Abstract A083: Diversifying breast cancer clinical trial accrual: An approach to recruitment at a Comprehensive Cancer Center Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-A083 |
0.459 |
|
| 2020 |
Chavez NR, Nunez A, Wong AK, Chavez TA, Rippberger E, Thai C, Sanchez A, Idassi OM, Round KM, Kennedy K, Robles M, Alva-Ornelas JA, Tomsic J, Kalu CMK, Kruper LL, ... ... Seewaldt VL, et al. Abstract A082: Influencing women's attitudes toward participation in breast cancer clinical research: Improving inclusion of women of color Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-A082 |
0.426 |
|
| 2019 |
Tossas-Milligan K, Shalabi S, Jones V, Keely PJ, Conklin MW, Elicerie KW, Winn R, Sistrunk C, Geradts J, Miranda-Carboni G, Dietze EC, Yee LD, Seewaldt VL. Mammographic density: intersection of advocacy, science, and clinical practice. Current Breast Cancer Reports. 11: 100-110. PMID 33312342 DOI: 10.1007/S12609-019-00316-4 |
0.385 |
|
| 2019 |
Fatima I, El-Ayachi I, Playa HC, Alva-Ornelas JA, Khalid AB, Kuenzinger WL, Wend P, Pence JC, Brakefield L, Krutilina RI, Johnson DL, O'Regan RM, Seewaldt V, Seagroves TN, Krum SA, et al. Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling. Cancers. 11. PMID 31861131 DOI: 10.3390/cancers11122039 |
0.332 |
|
| 2019 |
Tenvooren I, Jenks MZ, Rashid H, Cook KL, Muhlemann JK, Sistrunk C, Holmes J, Wang K, Bonin K, Hodges K, Lo HW, Shaikh A, Camarillo IG, Lelièvre SA, Seewaldt V, et al. Elevated leptin disrupts epithelial polarity and promotes premalignant alterations in the mammary gland. Oncogene. PMID 30670780 DOI: 10.1038/S41388-019-0687-8 |
0.435 |
|
| 2018 |
El Ayachi I, Fatima I, Wend P, Alva-Ornelas JA, Runke S, Kuenzinger WL, Silva J, Silva W, Gray JK, Lehr S, Barch HC, Krutilina RI, White AC, Cardiff R, Yee LD, ... ... Seewaldt V, et al. The WNT10B network is associated with survival and metastases in chemoresistant triple-negative breast cancer. Cancer Research. PMID 30563890 DOI: 10.1158/0008-5472.CAN-18-1069 |
0.341 |
|
| 2018 |
Tossas-Milligan KY, Rauscher GH, Campbell R, Seewaldt V. Abstract PR08: Tumor masking or tumor aggressiveness? A structural equations modeling approach to estimate the impact of breast density on breast cancer stage, overall and by race Cancer Epidemiology, Biomarkers & Prevention. 27. DOI: 10.1158/1538-7755.Disp17-Pr08 |
0.529 |
|
| 2018 |
Zhao R, Pien IJ, Seewaldt VL, Li C, Hollenbeck ST. Abstract 13: DNA Damage Signaling and Cell Senescence in BRCA1 Mutated Adipose Stem Cells Leads to Breast Cancer Progression. Plastic and Reconstructive Surgery. Global Open. 6: 10-11. DOI: 10.1097/01.Gox.0000533878.13970.54 |
0.418 |
|
| 2017 |
Glass OK, Bowie M, Fuller J, Darr D, Usary J, Boss K, Choudhury KR, Liu X, Zhang Z, Locasale JW, Williams C, Dewhirst MW, Jones LW, Seewaldt V. Differential response to exercise in claudin-low breast cancer. Oncotarget. 8: 100989-101004. PMID 29254140 DOI: 10.18632/oncotarget.21054 |
0.332 |
|
| 2017 |
Dietze EC, Chavez TA, Seewaldt VL. Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology. The American Journal of Pathology. PMID 29128565 DOI: 10.1016/j.ajpath.2017.09.018 |
0.359 |
|
| 2017 |
Wang X, Yao J, Wang J, Zhang Q, Brady SW, Arun B, Seewaldt V, Yu D. Targeting Aberrant p70S6K Activation for Estrogen Receptor Negative Breast Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 28877935 DOI: 10.1158/1940-6207.Capr-17-0106 |
0.493 |
|
| 2017 |
Zhao R, Pien IJ, Liu X, Seewaldt VL, Li C, Hollenbeck ST. Abstract 42: Human Adipose-Derived Stem Cells with BRCA Mutation Promote Breast Tumor Cell Migration. Plastic and Reconstructive Surgery. Global Open. 5: 33. DOI: 10.1097/01.Gox.0000516563.61930.B8 |
0.385 |
|
| 2016 |
Acharya S, Xu J, Wang X, Jain S, Wang H, Zhang Q, Chang CC, Bower J, Arun B, Seewaldt V, Yu D. Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinib. American Journal of Cancer Research. 6: 981-95. PMID 27293993 |
0.5 |
|
| 2016 |
Krishnan V, Mitchell K, Miska J, George S, Shaw P, Seewaldt V, Lesniak M, Chekmareva M, Becker L, Parkash V, Miranti C, Rinker-Schaeffer C. Abstract A82: Ovarian cancer cells hijack immune functions of omental milky spots for metastatic colonization. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-A82 |
0.428 |
|
| 2015 |
Seewaldt V, Riley S. Group visits for women at high risk for breast cancer: Facilitated education and support sessions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 30. PMID 28147787 DOI: 10.1200/Jco.2015.33.28_Suppl.30 |
0.587 |
|
| 2015 |
Bowie M, Pilie P, Wulfkuhle J, Lem S, Hoffman A, Desai S, Petricoin E, Carter A, Ambrose A, Seewaldt V, Yu D, Ibarra Drendall C. Fluoxetine induces cytotoxic endoplasmic reticulum stress and autophagy in triple negative breast cancer. World Journal of Clinical Oncology. 6: 299-311. PMID 26677444 DOI: 10.5306/Wjco.V6.I6.299 |
0.597 |
|
| 2015 |
Krishnan V, Clark R, Chekmareva M, Johnson A, George S, Shaw P, Seewaldt V, Rinker-Schaeffer C. In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose. Journal of Visualized Experiments : Jove. PMID 26555178 DOI: 10.3791/52721 |
0.458 |
|
| 2015 |
Jain S, Wang X, Chang CC, Ibarra-Drendall C, Wang H, Zhang Q, Brady SW, Li P, Zhao H, Dobbs J, Kyrish M, Tkaczyk TS, Ambrose A, Sistrunk C, Arun B, ... ... Seewaldt VL, et al. Src Inhibition Blocks c-Myc Translation and Glucose Metabolism to Prevent the Development of Breast Cancer. Cancer Research. PMID 26383165 DOI: 10.1158/0008-5472.Can-14-2345 |
0.536 |
|
| 2015 |
Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, ... ... Seewaldt V, et al. Breast Cancer Risk Reduction, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 880-915. PMID 26150582 DOI: 10.6004/Jnccn.2015.0105 |
0.638 |
|
| 2015 |
Girard BJ, Regan Anderson TM, Welch SL, Nicely J, Seewaldt VL, Ostrander JH. Cytoplasmic PELP1 and ERRgamma protect human mammary epithelial cells from Tam-induced cell death. Plos One. 10: e0121206. PMID 25789479 DOI: 10.1371/journal.pone.0121206 |
0.502 |
|
| 2015 |
Dietze EC, Sistrunk C, Miranda-Carboni G, O'Regan R, Seewaldt VL. Triple-negative breast cancer in African-American women: disparities versus biology. Nature Reviews. Cancer. 15: 248-54. PMID 25673085 DOI: 10.1038/Nrc3896 |
0.457 |
|
| 2015 |
Desai SR, Dietze EC, Skaar D, Jirtle RL, Seewaldt VL. Abstract PR11: Loss of imprinting: Tying prenatal diet to the aggressive biology of triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-Pr11 |
0.449 |
|
| 2015 |
Sistrunk C, Ambrose A, Carter A, Seewaldt V. Abstract B52: Pilot study: Random periareolar fine needle aspiration (RPFNA) accurately depicts biochemical phenotype displayed in breast tissues of high risk African American women Cancer Epidemiology, Biomarkers & Prevention. 24. DOI: 10.1158/1538-7755.Disp14-B52 |
0.636 |
|
| 2015 |
Ostrander JH, Girard BJ, Knutson T, Kuker B, Seewaldt V. Abstract P4-05-03: Cytoplasmic PELP1 promotes breast cancer initiation via NF-κB signaling Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-05-03 |
0.658 |
|
| 2014 |
Seewaldt V. ECM stiffness paves the way for tumor cells. Nature Medicine. 20: 332-3. PMID 24710372 DOI: 10.1038/Nm.3523 |
0.514 |
|
| 2014 |
Skaar D, Gould M, Jirtle R, Seewaldt V. Abstract CN02-03: Altered imprinted gene DMR regulatory methylation in breast cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-Cn02-03 |
0.595 |
|
| 2014 |
Desai S, Skaar D, Dietze E, Ambrose A, Jirtle R, Seewaldt V. Abstract C65: Loss of imprinting of KCNK9 in African American women with triple-negative breast cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C65 |
0.63 |
|
| 2014 |
Drendall CI, Barry W, Ramos C, Tolbert N, Geradts J, Petricoin E, Seewaldt V. Abstract C16: Feasibility study: Protein profiling of primary breast cancers from premenopausal women Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C16 |
0.587 |
|
| 2014 |
Sistrunk C, Robertson S, Ambrose A, Drendall CI, Seewaldt V. Abstract A46: Breast cancers come out of nowhere: A two part Durham Community/Duke partnership to identify signaling pathways during the initiation of triple-negative breast cancer in African American women Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-A46 |
0.633 |
|
| 2014 |
Seewaldt V, Skaar D, Dietze E, Desai S, Jirtle R. Abstract 28: Chemoprevention strategies to target abnormal imprinting in high-risk African American women who do or do not carry a BRCA1 mutation Cancer Research. 74: 28-28. DOI: 10.1158/1538-7445.Cansusc14-28 |
0.536 |
|
| 2014 |
Kumar N, Pien I, Bowie M, Ibarra-Drendall C, Sweede M, Seewaldt V, Hollenbeck ST. Abstract P42: The Role of Obesity and Breast Adipose Tissue in Breast Cancer Formation Plastic and Reconstructive Surgery. 133: 221. DOI: 10.1097/01.Prs.0000445042.47203.D7 |
0.556 |
|
| 2013 |
Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V, Kuperwasser C. Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis. Cancer Research. 73: 6080-93. PMID 23959857 DOI: 10.1158/0008-5472.Can-13-0926 |
0.582 |
|
| 2013 |
Hollenbeck S, Keely P, Seewaldt V. Mammographic density: intersection of science, the law, and clinical practice. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. PMID 23714458 DOI: 10.1200/EdBook_AM.2013.33.e63 |
0.432 |
|
| 2012 |
Hoffman AW, Ibarra-Drendall C, Espina V, Liotta L, Seewaldt V. Ductal carcinoma in situ: challenges, opportunities, and uncharted waters. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 40-4. PMID 24451705 DOI: 10.14694/EdBook_AM.2012.32.40 |
0.534 |
|
| 2012 |
Seewaldt VL. Cancer: Destiny from density. Nature. 490: 490-1. PMID 23099400 DOI: 10.1038/490490a |
0.303 |
|
| 2012 |
D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, ... ... Seewaldt VL, et al. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system. Plos One. 7: e45684. PMID 23049838 DOI: 10.1371/Journal.Pone.0045684 |
0.724 |
|
| 2012 |
Hoffman A, Pellenberg R, Drendall CI, Seewaldt V. Comparison of Random Periareolar Fine Needle Aspirate versus Ductal Lavage for Risk Assessment and Prevention of Breast Cancer. Current Breast Cancer Reports. 4: 180-187. PMID 22924092 DOI: 10.1007/S12609-012-0081-9 |
0.604 |
|
| 2012 |
Henderson BE, Lee NH, Seewaldt V, Shen H. The influence of race and ethnicity on the biology of cancer. Nature Reviews. Cancer. 12: 648-53. PMID 22854838 DOI: 10.1038/Nrc3341 |
0.415 |
|
| 2012 |
Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF, Wulfkuhle J, Liotta LA, Lem S, Baker JC, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, ... ... Seewaldt VL, et al. Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways. Breast Cancer Research and Treatment. 132: 487-98. PMID 21647677 DOI: 10.1007/S10549-011-1609-9 |
0.394 |
|
| 2012 |
Skaar DA, Seewaldt VL, Gould MN, Jirtle RL. Abstract 4043: Loss of imprinting of KCNK9 in breast cancer Cancer Research. 72: 4043-4043. DOI: 10.1158/1538-7445.Am2012-4043 |
0.461 |
|
| 2012 |
Scheri R, Power S, Marks J, Seewaldt V, Marcom K, Hwang S. Abstract P4-13-06: Association of Age, Obesity and Incident Breast Cancer Phenotypes Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P4-13-06 |
0.506 |
|
| 2012 |
Seewaldt V, Hoffman A, Ibarra-Drendall C. Abstract P1-03-01: Evidence for the Warburg effect in mammary atypia from high-risk African American women. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P1-03-01 |
0.559 |
|
| 2012 |
Ibarra-Drendall C, Troch MM, Barry WT, Broadwater G, Petricoin EF, Wulfkuhle J, Liotta LA, Lem S, Baker JC, Ford AC, Wilke LG, Zalles C, Kuderer NM, Hoffman AW, Shivraj M, ... ... Seewaldt VL, et al. Erratum: Pilot and feasibility study: Prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways (Breast Cancer Research and Treatment (2012) 132 (487-498) DOI: 10.1007/s10549-011-1609-9) Breast Cancer Research and Treatment. 135. DOI: 10.1007/S10549-012-2227-X |
0.512 |
|
| 2011 |
Ibarra-Drendall C, Dietze EC, Seewaldt VL. Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin? Current Breast Cancer Reports. 3: 142-150. PMID 21949568 DOI: 10.1007/s12609-011-0050-8 |
0.521 |
|
| 2011 |
Pilie PG, Ibarra-Drendall C, Troch MM, Broadwater G, Barry WT, Petricoin EF, Wulfkuhle JD, Liotta LA, Lem S, Baker JC, Stouder A, Ford AC, Wilke LG, Zalles CM, Mehta P, ... ... Seewaldt VL, et al. Protein microarray analysis of mammary epithelial cells from obese and nonobese women at high risk for breast cancer: feasibility data. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 476-82. PMID 21242333 DOI: 10.1158/1055-9965.Epi-10-0847 |
0.534 |
|
| 2011 |
Kravchenko J, Akushevich I, Seewaldt VL, Abernethy AP, Lyerly HK. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms. Breast Cancer Research and Treatment. 128: 483-93. PMID 21225455 DOI: 10.1007/s10549-011-1347-z |
0.511 |
|
| 2011 |
Millon SR, Ostrander JH, Brown JQ, Raheja A, Seewaldt VL, Ramanujam N. Uptake of 2-NBDG as a method to monitor therapy response in breast cancer cell lines. Breast Cancer Research and Treatment. 126: 55-62. PMID 20390344 DOI: 10.1007/S10549-010-0884-1 |
0.465 |
|
| 2011 |
Ibarra-Drendall C, Ford A, Tolbert N, Frye E, Lee L, Broadwater G, Barry W, Petricoin E, Liota L, Seewaldt V. Abstract CN07-03: IL6 and AKT as targets for chemoprevention Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-Cn07-03 |
0.549 |
|
| 2011 |
Frye EL, Ford A, Banks L, Boyce X, Robertson S, Ibarra-Drendall C, Seewaldt V. Abstract B9: Community strategies for investigating the biology of breast and cervical cancer initiation in African-American women Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B9 |
0.59 |
|
| 2011 |
Shafer CM, Seewaldt VL, Lo JY. Segmentation of adipose and glandular tissue for breast tomosynthesis imaging using a 3D hidden-Markov model trained on breast MRIs Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7961. DOI: 10.1117/12.878137 |
0.39 |
|
| 2011 |
Shafer CM, Seewaldt VL, Lo JY. Validation of a 3D hidden-Markov model for breast tissue segmentation and density estimation from MR and tomosynthesis images Proceedings of the 2011 Biomedical Sciences and Engineering Conference: Image Informatics and Analytics in Biomedicine, Bsec 2011. DOI: 10.1109/BSEC.2011.5872317 |
0.461 |
|
| 2010 |
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Loftus L, Macdonald DJ, ... ... Seewaldt V, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 8: 1112-46. PMID 20971838 DOI: 10.6004/Jnccn.2010.0083 |
0.606 |
|
| 2010 |
Ostrander JH, McMahon CM, Lem S, Millon SR, Brown JQ, Seewaldt VL, Ramanujam N. Optical redox ratio differentiates breast cancer cell lines based on estrogen receptor status. Cancer Research. 70: 4759-66. PMID 20460512 DOI: 10.1158/0008-5472.Can-09-2572 |
0.411 |
|
| 2010 |
Seewaldt VL. Comments and response on the USPSTF recommendation on screening for breast cancer. Annals of Internal Medicine. 152: 541-2; author reply . PMID 20157105 DOI: 10.7326/0003-4819-152-8-201004200-00205 |
0.48 |
|
| 2010 |
Seewaldt VL, Ibarra-Drendall C, Pilie P, Barry W, Broadwater G, Petricoin E. Abstract A108: Phosphoprotein network activation during breast cancer initiation Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-A108 |
0.483 |
|
| 2010 |
Seewaldt VL, Ibarra C, Yee LD, Wilke LG, Kulkarni S, Wood M, Garber J, Ford A. Abstract A20: Random periareolar fine‐needle aspiration is highly reproducible in a CALGB multi‐institutional cross‐sectional study Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-A20 |
0.572 |
|
| 2010 |
Pilie PG, Ibarra C, Troch M, Dietze E, Broadwater G, Barry W, Petricoin C, Seewaldt VL. Abstract A15: Proteomic profiling of early mammary carcinogenesis: Targeting dysregulated protein pathways with tailored therapies Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcmusa10-A15 |
0.468 |
|
| 2009 |
Wilke LG, Broadwater G, Rabiner S, Owens E, Yoon S, Ghate S, Scott V, Walsh R, Baker J, Soo MS, Ibarra-Drendall C, Stouder A, Robertson S, Barron A, Seewaldt V. Breast self-examination: defining a cohort still in need. American Journal of Surgery. 198: 575-9. PMID 19800471 DOI: 10.1016/J.Amjsurg.2009.06.012 |
0.614 |
|
| 2009 |
Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, Feng X, Seewaldt VL, Muller WJ, Sahin A, Hung MC, et al. 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell. 16: 195-207. PMID 19732720 DOI: 10.1016/J.Ccr.2009.08.010 |
0.499 |
|
| 2009 |
Ibarra-Drendall C, Wilke LG, Zalles C, Scott V, Archer LE, Lem S, Yee LD, Lester J, Kulkarni S, Murekeyisoni C, Wood M, Wilson K, Garber J, Gentry C, Stouder A, ... ... Seewaldt VL, et al. Reproducibility of random periareolar fine needle aspiration in a multi-institutional Cancer and Leukemia Group B (CALGB) cross-sectional study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1379-85. PMID 19383884 DOI: 10.1158/1055-9965.Epi-08-1210 |
0.477 |
|
| 2009 |
Vasilatos SN, Broadwater G, Barry WT, Baker JC, Lem S, Dietze EC, Bean GR, Bryson AD, Pilie PG, Goldenberg V, Skaar D, Paisie C, Torres-Hernandez A, Grant TL, Wilke LG, ... ... Seewaldt VL, et al. CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 901-14. PMID 19258476 DOI: 10.1158/1055-9965.Epi-08-0875 |
0.718 |
|
| 2009 |
Carson JW, Carson KM, Porter LS, Keefe FJ, Seewaldt VL. Yoga of Awareness program for menopausal symptoms in breast cancer survivors: Results from a randomized trial Supportive Care in Cancer. 17: 1301-1309. PMID 19214594 DOI: 10.1007/S00520-009-0587-5 |
0.353 |
|
| 2008 |
Baker JC, Ostrander JH, Lem S, Broadwater G, Bean GR, D'Amato NC, Goldenberg VK, Rowell C, Ibarra-Drendall C, Grant T, Pilie PG, Vasilatos SN, Troch MM, Scott V, Wilke LG, ... ... Seewaldt VL, et al. ESR1 promoter hypermethylation does not predict atypia in RPFNA nor persistent atypia after 12 months tamoxifen chemoprevention. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 1884-90. PMID 18708376 DOI: 10.1158/1055-9965.Epi-07-2696 |
0.688 |
|
| 2007 |
Bean GR, Bryson AD, Pilie PG, Goldenberg V, Baker JC, Ibarra C, Brander DM, Paisie C, Case NR, Gauthier M, Reynolds PA, Dietze E, Ostrander J, Scott V, Wilke LG, ... ... Seewaldt VL, et al. Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 6834-41. PMID 18006786 DOI: 10.1158/1078-0432.Ccr-07-0407 |
0.394 |
|
| 2007 |
Bevers TB, Armstrong DK, Arun B, Carlson RW, Cowan KH, Daly MB, Fleming I, Garber JE, Gemignani M, Gradishar WJ, Krontiras H, Kulkarni S, Laronga C, Lawton T, Loftus L, ... ... Seewaldt V, et al. Breast cancer risk reduction. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 676-701. PMID 17927926 |
0.542 |
|
| 2007 |
Goldenberg VK, Seewaldt VL, Scott V, Bean GR, Broadwater G, Fabian C, Kimler B, Zalles C, Lipkus IM. Atypia in random periareolar fine-needle aspiration affects the decision of women at high risk to take tamoxifen for breast cancer chemoprevention. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1032-4. PMID 17507634 DOI: 10.1158/1055-9965.EPI-06-0910 |
0.573 |
|
| 2007 |
Seewaldt VL, Scott V. Images in clinical medicine. Rapid progression of basal-type breast cancer. The New England Journal of Medicine. 356: e12. PMID 17392297 DOI: 10.1056/NEJMicm063760 |
0.463 |
|
| 2007 |
Seewaldt VL, Goldenberg V, Jones LW, Peace C, Broadwater G, Scott V, Bean GR, Wilke LG, Zalles CM, Demark-Wahnefried W. Overweight and obese perimenopausal and postmenopausal women exhibit increased abnormal mammary epithelial cytology. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 613-6. PMID 17372261 DOI: 10.1158/1055-9965.Epi-06-0878 |
0.326 |
|
| 2007 |
Bean GR, Ibarra Drendall C, Goldenberg VK, Baker JC, Troch MM, Paisie C, Wilke LG, Yee L, Marcom PK, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Scott V, Seewaldt VL. Hypermethylation of the breast cancer-associated gene 1 promoter does not predict cytologic atypia or correlate with surrogate end points of breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 50-6. PMID 17220331 DOI: 10.1158/1055-9965.EPI-06-0598 |
0.589 |
|
| 2006 |
Bean GR, Kimler BF, Seewaldt VL. Long-term raloxifene in a woman at high risk for breast cancer. The New England Journal of Medicine. 355: 1620-2. PMID 17035661 DOI: 10.1056/NEJMc061954 |
0.479 |
|
| 2006 |
Seewaldt V. Dr. Susan Love’s Breast Book: New Edition 2005 Sexuality Research and Social Policy. 3: 70-72. DOI: 10.1525/Srsp.2006.3.2.70 |
0.518 |
|
| 2005 |
Bean GR, Scott V, Yee L, Ratliff-Daniel B, Troch MM, Seo P, Bowie ML, Marcom PK, Slade J, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Baker JC, Wilke LG, ... Seewaldt VL, et al. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 790-8. PMID 15824145 DOI: 10.1158/1055-9965.EPI-04-0580 |
0.356 |
|
| 2004 |
Ratliff BE, Bean G, Marcom PK, Scott JV, Yee L, Kimler BF, Fabian CJ, Zalles CM, Shaw H, Seewaldt VL. RARbeta P2 promoter methylation: Potential biomarker for use with breast Random Periareolar Fine Needle Aspiration in breast cancer risk assessment. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1014. PMID 28014601 DOI: 10.1200/jco.2004.22.14_suppl.1014 |
0.533 |
|
| 2003 |
Yee LD, Guo Y, Bradbury J, Suster S, Clinton SK, Seewaldt VL. The antiproliferative effects of PPARgamma ligands in normal human mammary epithelial cells. Breast Cancer Research and Treatment. 78: 179-92. PMID 12725418 DOI: 10.1023/A:1022978608125 |
0.33 |
|
| 2002 |
Treuting PM, Chen LI, Buetow BS, Zeng W, Birkebak TA, Seewaldt VL, Sommer KM, Emond M, Maggio-Price L, Swisshelm K. Retinoic acid receptor beta2 inhibition of metastasis in mouse mammary gland xenografts. Breast Cancer Research and Treatment. 72: 79-88. PMID 12000222 DOI: 10.1023/A:1014906529407 |
0.379 |
|
| 2002 |
Seewaldt VL. The Breast Cancer Wars: Hope, Fear, and the Pursuit of a Cure in Twentieth-Century America Jama: the Journal of the American Medical Association. 287: 917-918. DOI: 10.1001/jama.287.7.917 |
0.545 |
|
| 1999 |
Yee LD, Sabourin CL, Liu L, Li HM, Smith PJ, Seewaldt V, Kniss DA. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. International Journal of Oncology. 15: 967-73. PMID 10536181 DOI: 10.3892/ijo.15.5.967 |
0.377 |
|
| Show low-probability matches. |